(This article isTMT Pro (Professional Edition)(For user exclusive use)
"Titanium Media Pro Weekly Report" aggregates domestic and international financing events and hotspots of the week through the TMTBase global primary market database of Titanium Media, aiming to enable investors and entrepreneur users to clearly understand trends, grasp investment logic, and seize the latest industrial opportunities in a time and data-intensive manner.
Industry Report Catalog
The full report is 9,064 words with 6 illustrations.
1. Industry Key Introduction
2. Primary Market Dynamics
2.1, China's Two-Week Financing Dynamics (Figure: Financing Project Details/Fields/Stages)
2.2, Project Recommendation by Titanium Media Pro in China
2.3, Overseas Two-Week Financing Dynamics (Figure: Financing Project Details/Field/Stage)
2.4, Overseas Titanium Media Pro·Project Recommendation
3. Industry Observation
4. Industry Policy
For project exposure, please send project materials to: tmtpro@tmtpost.com
Key Reading Points
A total of 57 global investment and financing projects in the medical and health field were recorded, including 31 domestic financings and 26 overseas financings. In terms of financing areas, there were 14 investment and financing projects in the domestic medical device and hardware sector, ranking first, and 10 in the pharmaceuticals sector, ranking second; overseas, the pharmaceuticals sector saw 7 investment and financing projects, ranking first, while the medical device and hardware sector had 5, ranking second.
In terms of domestic investment and financing, in the pharmaceutical field, the new generation siRNA drug developer "Argo" completed a 300 million yuan A+ round of financing; in the medical device and hardware field, the ventricular assist device R&D producer "Rocketheart Technology Co., Ltd." completed more than 100 million yuan of financing.
In terms of overseas investment and financing, in the pharmaceutical field, "Gate Bioscience," a provider of molecular-gated discovery platforms, completed a $60 million Series A round of financing; in the medical device and hardware field, "SkyCell," a producer of medical vaccine transport equipment, received $57 million in financing.
From October 30, 2023, to November 5, 2023, the TMTBASE global primary market database of Titanium Media recorded a total of 57 financing events in the healthcare sector, both domestically and internationally, including 31 domestic financings and 26 international financings.
China Weekly Financing Updates
✔. In the past week, the TMTBASE global primary market database of Titanium Media recorded a total of 31 financing and investment events in the medical and health field in China, with a week-on-week increase of 34.78%.
✔. In terms of the number of financings, there were 14 investment and financing activities in the medical device and hardware field, 10 in the pharmaceuticals field, 5 in the medical informatization field, and 1 each in the biotechnology, health consumption, and medical services fields.
✔. In terms of financing rounds, there is 1 seed round, 8 angel rounds, 1 Pre-A round, 1 Pre-A+ round, 2 A rounds, 1 A+ round, 1 Pre-B round, 2 B rounds, 1 B+ round, 2 D rounds, 9 equity investments, 1 strategic investment, and 1 merger & acquisition.
✔. There were 5 disclosed financing projects with amounts over 100 million RMB in the past week, including 3 in the medical device and hardware field and 2 in the pharmaceutical field.
Recommended Projects by Titanium Media Pro in China
Pharmaceuticals
"Argo Biopharma" Completes RMB 300 Million Series A+ Financing
Recently, "Argo" has completed a 300 million RMB A+ round of financing. This round was led by SDIC Capital, with participation from Huagai Capital, Yuanxi Haihe Fund, and existing shareholder Sanyi Innovation Investment. The proceeds will be used to further advance the global development of four clinical pipelines, the discovery of multiple preclinical candidate drug molecules (PCC), the iterative upgrade of modification technology platforms and extrahepatic delivery technology platforms, as well as the enhancement of the company's professional team.
Argo, established in April 2021, focuses on the development of siRNA drugs and was founded by several scientists with extensive experience in siRNA drug development. The company is committed to developing a new generation of siRNA drugs to provide urgently needed and better treatment options for patients worldwide. It is reported that the Argo team has many years of professional experience in all aspects of RNAi drug development, including nucleic acid sequence design, chemical modification, GalNAc delivery technology, extrahepatic tissue targeting delivery technology, oligonucleotide synthesis, and CMC. Argo has already built a complete nucleic acid drug development platform.
Medical Devices and Hardware
"Rocketheart Technology Co., Ltd." Completes Over 100 Million Yuan in Financing
Recently, "Rocketheart Technology Co., Ltd." completed a financing round of over 100 million RMB, jointly invested by Xingrun Haihe and Xingrun Assets. This round of financing aims to fully leverage Rocketheart's continuous R&D capabilities and further expand the company’s product portfolio in the full-cycle heart failure domain.
In July 2022, the company's first product, "Rocketheart" HeartCon implantable left ventricular assist system, was approved for marketing by the National Medical Products Administration (NMPA). It became the first artificial heart product in China to strictly complete a clinical trial involving 50 cases according to the clinical trial protocol and obtain a full product registration certificate.
....
For overseas weekly financing events, recommended projects, and policy updates this week, please refer to the full report.
----------------
*This is the simplified version of Pro Weekly Report*
To view the full report, please clickhttps://www.tmtpost.com/proBecome a Titanium Media Pro user to view the full "Titanium Media Pro Weekly Report"
"TMTBASE Database" is an independent, precise, and efficient professional equity investment information platform under the Titanium Media Group, offering services including primary market research reports, enterprise data query services, equity crowdfunding project analysis services, and offline venture capital community services.
The report has been fully launched on the VIP Professional Edition of TMTPOST.Click the link Become a professional user of Titanium Media (https://www.tmtpost.com/pro), to obtain more investment and financing information services, more primary market research report businesses also include:Become a professional user of Titanium Media to read all professional content without limitation.